COPD: Page 9

American Thoracic Society calls for research into multiple key areas
The organization said more research is needed to improve outcomes in patients with COPD and cardiovascular disease.
August 15, 2024
Female researcher in a lab setting working on a touch screen monitor
FDA grants Tezspire breakthrough therapy designation for COPD
The announcement was based on encouraging results from earlier trials.
August 9, 2024
Tezpire lung treatment pre-filled syringe.
COPD not associated with increased mortality in COVID patients
Researchers studied patients diagnosed with the Omicron variant of COVID-19.
August 1, 2024
Abstract image of COVID-19 virus cell.
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
ICER issues access and affordability alert for ensifentrine
The high cost of the drug could lead to increased costs for other services within the health care system.
July 24, 2024
Stethoscope in the shape of a dollar sign.
Adults no more susceptible to common infections than prior to COVID pandemic
The prevalence of asthma, COPD, did not increase in 2023 compared to 2019.
July 24, 2024
Graph showing a decline in respiratory and infectious illnesses in adults prior to and after the COVID-19 pandemic.
European patent issued for brilaroxazine
Patent covers the usage for treatment of pulmonary hypertension in COPD patients.
July 15, 2024
Home caregiver measuring blood pressure of a female patient at home
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
European Union approves Dupixent
Inaugural approval of the new treatment for uncontrolled COPD.
July 11, 2024
Map of the European Union.
Patients with COPD face psychological challenges
Canadian study finds that social and clinical support may be key to treatment.
July 11, 2024
Woman with a comforting hand on her shoulder.
FDA approves ensifentrine for COPD maintenance treatment
Agency action makes Ohtuvayre the first novel mechanism for COPD care in 20 years.
July 2, 2024
Ensifentrine mechanism of action.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
FDA grants clearance for clinical deterioration software
New suite can accurately identify high-risk hospitalized patients across conditions, including COPD.
July 2, 2024
Blurred image of a doctor in the background pressing an AI button in the foreground.
Prevalence of COPD is higher in LGBTQ+ communities
New journal articles call for more research, educational efforts in these communities.
June 27, 2024
Image of a stethoscope on a rainbow flag.
Increased omega-3 levels may benefit patients with COPD
Omega-3 fatty acids have previously been linked to anti-inflammatory responses in COPD.
June 27, 2024
Image of healthy foods with the words omega 3 in the middle.
Previous Page
Page 9 of 17
Next Page
Most Popular
GINA releases 2025 asthma guidelines update
Brinsupri becomes first FDA-approved therapy for NCFB
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
The best and worst states for lung health, COPD
Researchers create 3D-printed living lung tissue
CHEST publishes new guideline on NSCLC management